Summer student, Basel Institute for Immunology, Switzerland
1985 - 1987
Diploma Thesis, German Cancer Research Center, Heidelberg, Germany, V. Schirrmacher
1981 - 1985
Human Biology, University of Marburg, Germany
Scientific Degrees
Habilitation
"Immunology and Cell Biology", University of Tübingen, Germany, 2000, Prof. H.-G. Rammensee
PhD thesis
University of Marburg and Max-Planck-Institute for Biology, Tübingen, Germany, 1989, H.-G. Rammensee
Professional Career
2003 - present
Director, Institute for Immunology at the University Medical Center of the Johannes Gutenberg University Mainz
2002
Appointment as Full Professor of Immunology at the University of Marburg (declined)
1996 - 2003
Group leader, Institute for Cell Biology, Dept. of Immunology, University of Tübingen, Germany
1993 - 1996
Group leader, German Cancer Research Center, Heidelberg, Germany
1990 - 1993
Postdoc, Stanford University Medical School (Dr. Mark Davis), Stanford, USA
1990 - 1993
Postdoc, Max-Planck-Institute for Biology, Tübingen, Germany
Honours and Other Activities
2013 - present
Ombudsman for scientific misconduct at the Paul Ehrlich Institute, Langen, Germany
2012 - present
Member Scientific Advisory Board TWINCORE GmbH, Hannover, Germany
2012 - 2016
Member Scientific Advisory Board TRON gGmbH, Mainz
2011 - present
Member Scientific Advisory Board of the Max Planck Graduate Center Mainz
Member of DGfI scientific advisory board
2009 - 2013
Deputy Speaker of the Graduate School 1043 "Immunotherapy" at the University Medical Center of the Johannes Gutenberg University Mainz
2008 - 2017
Speaker of the "Forschungszentrum Immuntherapie" (FZI) at the University Medical Center of the Johannes Gutenberg University Mainz
2008 - 2016
Member of DFG Review Board 204 "Microbiology, Virology, Immunology"
2005 - 2008
Coordinator (with Prof. C. Huber) of the Immunology Excellence Cluster "Immunointervention" of the Johannes Gutenberg University Mainz
2004 - 2008
Deputy speaker, SFB 432
2000
Georges Köhler Award, German Immunological Society
1993
Scholarship of the German Science Foundation
Selected Publications
Probst HC, Muth S, Schild H (2014) Regulation of the tolerogenic function of steady-state DCs. Eur J Immunol. 44:927-33
Muth S, Schütze K, Schild H, Probst HC (2012) Release of dendritic cells from cognate CD4+ T-cell recognition results in impaired peripheral tolerance and fatal CTL autoimmunity. Proc Natl Acad Sci USA 109:9059-64
Srokowski CC, Masri J, Hövelmeyer N, Krembel AK, Tertilt C, Strand D, Mahnke K, Massoumi R, Waisman A*, and Schild H* (2009) Naturally occuring short splice variant of CYLD positively regulates dendritic cell function. Blood 113:5891-5 * joint senior authors
Reinecke J, Tenzer , Hasselmayer O, Rupnik M, Schrattenholz A, Schild H*, von Eichel-Streiber C* (2007) Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446:415-9 * joint senior authors
Osterloh P, Linkemann K, Tenzer S, Rammensee H-G, Radsak MP, Busch DH, Schild H (2006) Proteasome shape the repertoire of T cells participating in antigen-specific immune responses. Proc Natl Acad Sci USA 103:5042-7
Warger T, Hilf N, Rechtsteiner G, Carrick DM, Jonuleit H, von Landenberg P, Rammensee H-G, Nicchitta CV, Radsak MP, Schild H (2006) Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J Biol Chem 281:22545-53
Toes REM, Nussbaum AK, Degermann S, Schirle M, Emmerich NPN, Kraft M, Laplace C, Zwinderman A, Dick TP, Müller J, Schönfisch B, Schmid C, Fehling HJ, Stevanovic S, Rammensee HG, Schild H (2001) Discrete cleavage motifs of constitutive and immuno-proteasomes revealed by quantitative analysis of cleavage products. J Exp Med 194:1-12
Stoltze L, Schirle M, Schwarz G, Schröter C, Thompson MW, Hersh LB, Kalbacher H, Stevanovic S, Rammensee HG, Schild H (2000) Two new proteases in the MHC class I processing pathway. Nat Immunol 1:413-418
Schild H, Mavaddat N, Litzenberger C, Ehrich EW, Davis MM, Matis L, Draper RK, Chien YH (1994) The nature of major histocompatiblity complex recognition by γδ T cells. Cell 76:29-37
Schild H, Rötzschke O, Kalbacher H, Rammensee HG (1989) T lymphocyte tolerance to self proteins is limited by peptide presentation. Science 247:1587-1589